1. Home
  2. QSR vs ILMN Comparison

QSR vs ILMN Comparison

Compare QSR & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QSR
  • ILMN
  • Stock Information
  • Founded
  • QSR 1954
  • ILMN 1998
  • Country
  • QSR Canada
  • ILMN United States
  • Employees
  • QSR N/A
  • ILMN N/A
  • Industry
  • QSR
  • ILMN Medical Specialities
  • Sector
  • QSR
  • ILMN Health Care
  • Exchange
  • QSR Nasdaq
  • ILMN Nasdaq
  • Market Cap
  • QSR N/A
  • ILMN 13.1B
  • IPO Year
  • QSR 2006
  • ILMN 2000
  • Fundamental
  • Price
  • QSR $67.24
  • ILMN $99.14
  • Analyst Decision
  • QSR Buy
  • ILMN Buy
  • Analyst Count
  • QSR 19
  • ILMN 17
  • Target Price
  • QSR $77.84
  • ILMN $124.35
  • AVG Volume (30 Days)
  • QSR 4.0M
  • ILMN 2.4M
  • Earning Date
  • QSR 08-07-2025
  • ILMN 07-31-2025
  • Dividend Yield
  • QSR 3.68%
  • ILMN N/A
  • EPS Growth
  • QSR N/A
  • ILMN N/A
  • EPS
  • QSR 2.94
  • ILMN N/A
  • Revenue
  • QSR $8,776,000,000.00
  • ILMN $4,337,000,000.00
  • Revenue This Year
  • QSR $9.67
  • ILMN N/A
  • Revenue Next Year
  • QSR $3.31
  • ILMN $3.15
  • P/E Ratio
  • QSR $22.89
  • ILMN N/A
  • Revenue Growth
  • QSR 22.38
  • ILMN N/A
  • 52 Week Low
  • QSR $58.71
  • ILMN $68.70
  • 52 Week High
  • QSR $75.07
  • ILMN $156.66
  • Technical
  • Relative Strength Index (RSI)
  • QSR 46.08
  • ILMN 65.51
  • Support Level
  • QSR $66.86
  • ILMN $95.09
  • Resistance Level
  • QSR $68.78
  • ILMN $101.28
  • Average True Range (ATR)
  • QSR 1.11
  • ILMN 3.28
  • MACD
  • QSR 0.10
  • ILMN 0.10
  • Stochastic Oscillator
  • QSR 55.07
  • ILMN 78.82

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: